JGC
ONCS

J. Goldman & Co’s OncoSec Medical Incorporated ONCS Stock Holding History

J. Goldman & Co’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-35,920
Closed -$1.21M – 496
2021
Q3 		$1.68M Sell
35,920
-6,999
-16% -$354K 0.08% 205
2021
Q2 		$2.65M Sell
42,919
-1,977
-4% -$179K 0.1% 202
2021
Q1 		$4.71M Buy
44,896
+21,177
+89% +$2.9M 0.15% 162
2020
Q4 		$3.37M Buy
+23,719
New +$2.53M 0.17% 146
2018
Q1 		– Sell
-455
Closed -$163K – 484
2017
Q4 		$163K Buy
+455
New +$159K 0.01% 301

Other funds holding ONCS

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

J. Goldman & Co's ONCS Position: Q4 2021 in Review

J. Goldman & Co sold out of OncoSec Medical Incorporated (ONCS) in Q4 2021, closing a stake of 35,920 shares — an estimated $1.21M sold.

J. Goldman & Co first reported a position in ONCS in Q4 2017 and held it in 5 quarters. The position peaked at $4.71M in Q1 2021. 34 funds tracked by Wall St. Rank hold ONCS as of Q4 2021.

  • J. Goldman & Co reported no remaining OncoSec Medical Incorporated position as of Q4 2021 after selling out during the quarter.
  • J. Goldman & Co sold 35,920 OncoSec Medical Incorporated shares in Q4 2021, an estimated $1.21M.
  • J. Goldman & Co first reported a position in OncoSec Medical Incorporated in Q4 2017 and held it in 5 quarters.
  • J. Goldman & Co's OncoSec Medical Incorporated position peaked at $4.71M in Q1 2021.
  • 34 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2021.

Based on J. Goldman & Co's 13F filing for Q4 2021, filed 14 Feb 2022.